| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $59.8M | -85.8% |
| Cost of Revenue | $31.1M | -84.6% |
| Gross Profit | $28.7M | -86.9% |
| R&D Expense | $1.3M | -82.3% |
| SG&A Expense | $42.5M | -61.9% |
| Operating Income | -$13.7M | -112.8% |
| Interest Expense | $1.8M | -89.3% |
| Pre-tax Income | -$225.8M | -178.8% |
| Income Tax | $39.0M | +1684.5% |
| Net Income | -$136.0M | -153.2% |
| EPS (Basic) | -$1.23 | -0.8% |
| EPS (Diluted) | -$1.23 | -0.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $114.6M | +48.0% |
| Accounts Receivable | $0 | -100.0% |
| Inventory | $0 | -100.0% |
| Current Assets | $120.1M | -30.9% |
| Total Assets | $517.3M | +9.1% |
| Current Liabilities | $19.0M | -75.2% |
| Total Liabilities | $274.1M | -55.6% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$22.9M | -117.7% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | -$60.7M | -510.3% |
| Financing Cash Flow | $120.8M | +244.9% |
| Free Cash Flow | -$22.9M | -118.7% |
| $243.1M |
| +269.5% |